Granite Investment Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-273,007
Closed -$9.62M 323
2015
Q1
$9.62M Buy
273,007
+145,908
+115% +$4.94M 0.83% 23
2014
Q4
$4.08M Buy
127,099
+48,120
+61% +$1.39M 0.46% 60
2014
Q3
$2.22M Sell
78,979
-35,245
-31% -$1.07M 0.3% 90
2014
Q2
$3.45M Buy
114,224
+49,282
+76% +$1.36M 0.49% 54
2014
Q1
$1.8M Buy
+64,942
New +$1.7M 0.28% 98

Other funds holding BRLI

Granite Investment Partners's BRLI Position: Q2 2015 in Review

Granite Investment Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 273,007 shares — an estimated $9.62M sold.

Granite Investment Partners first reported a position in BRLI in Q1 2014 and held it in 5 quarters. The position peaked at $9.62M in Q1 2015. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

  • Granite Investment Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
  • Granite Investment Partners sold 273,007 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $9.62M.
  • Granite Investment Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q1 2014 and held it in 5 quarters.
  • Granite Investment Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $9.62M in Q1 2015.
  • 183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Granite Investment Partners's 13F filing for Q2 2015, filed 3 Aug 2015.